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Abstract
The placental epigenome plays a vital role in regulating mammalian growth and development.
Aberrations in placental DNA methylation are linked to several disease states, including intrauterine
growth restriction and preeclampsia. Studying the evolution and development of the placental epigenome
is critical to understanding the origin and progression of such diseases. Although high resolution
studies have found substantial variation between placental methylomes of different species, the nature
of methylome variation has yet to be characterized within any individual species. We conducted a study
of placental DNA methylation at high resolution in multiple strains and closely related species of house
mice (Mus musculus musculus, Mus m. domesticus, and M. spretus), across developmental timepoints
(embryonic days 15 to 18), and between two distinct layers (labyrinthine transport and junctional
endocrine). We observed substantial genome-wide methylation heterogeneity in mouse placenta compared
to other differentiated tissues. Species-specific methylation profiles were concentrated in retrotransposon
subfamilies, specifically RLTR10 and RLTR20 subfamilies. Regulatory regions such as gene promoters
and CpG islands displayed cross-species conservation, but showed strong differences between layers
and developmental timepoints. Partially methylated domains exist in the mouse placenta and widen
during development. Taken together, our results characterize the mouse placental methylome as a highly
heterogeneous and deregulated landscape globally, intermixed with actively regulated promoter and
retrotransposon sequences.
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Introduction
The placenta forms the crucial link between
mother and developing offspring during
mammalian pregnancy. It is responsible for
anchoring the fetus to the uterine wall, secretes
hormones that adapt maternal physiology,
prevents immunological rejection of the fetus,
and exchanges substrates between fetal and
maternal blood spaces. These functions are
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strongly conserved across mammals, despite
extraembryonic tissues displaying remarkable
morphological variation (Furukawa et al., 2014)
and placenta-specific genes accumulating a high
rate of nonsynonymous mutations (Chuong et al.,
2010; Hughes et al., 2000).
To effectively perform its wide array of
functions, the placenta is composed of multiple
trophoblast cell types which in the mouse are
organized into specialized zones. The junctional
zone lies proximal to the uterine wall and is
composed of invasive endocrine trophoblast
cells: the spongiotrophoblast, glycogen and
giant cells. These cell types are important
in promoting maternal immune tolerance,
decidual vascularization and maternal metabolic
adjustments that favour fetal nutrient delivery
(Hu and Cross, 2010). The other layer of the
mouse placenta is called the labyrinthine zone,
and lies proximal to the developing embryo. It is
composed of a dense network of fetal capillaries
and maternal blood spaces that are lined
with syncytiotrophoblast cells, which exchange
nutrients, gases and waste between mother and
fetus (Coan et al., 2005; Sferruzzi-Perri et al.,
2009). Genomic studies have provided insight
into placentation and diversification of placental
morphology (Cross, 2000; Roberts and Cooper,
2001), and the recent maturation of assays
designed to explore epigenetic features allows
us to study these phenomena at unprecedented
resolution.
DNA methylation occurs primarily on cytosines
of CpG dinucleotides in mammals (Bird, 1985).
Across the genome, most CpGs are methylated.
In somatic cells, hypomethylated intervals have
an average size of up to a few kilobases, although
larger intervals exist. These regions co-locate
with promoters and enhancers, and methylation
through these intervals is associated with gene
silencing and restriction of regulatory activity
(Jones, 2012). Retrotransposons are methylated
in most cell types, and this phenomenon is one
form of genomic defense against their expression
(Walsh et al., 1998). DNA methylation changes
in measurable and consistent ways as tissues
differentiate (Seisenberger et al., 2012) and can be
compared across species (Molaro et al., 2011; Pai
et al., 2011), enabling a precise characterization of
cellular and species identity.
In mammals, around 70% of the cytosines in
CpG dinucleotides are methylated in somatic cells
(Song et al., 2013), compared with closer to 50%
methylated in the placenta (Ehrlich et al., 1982;
Razin et al., 1984). A large body of evidence
suggests that the placental methylome plays a
critical functional role, and targeted assays have
implicated aberrant DNA methylation in several
placental disease phenotypes, including pre-
eclampsia (Hogg et al., 2013; Kulkarni et al., 2011;
Yuen et al., 2010) and growth restriction (Banister
et al., 2011; Lambertini et al., 2011). The recent
advent of whole genome bisulfite sequencing
(WGBS) has provided higher resolution maps
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of DNA methylation in the placenta that have
confirmed this lower methylation and detected
the presence of partially methylated domains
(PMDs), long stretches of the genome where
methylation levels drop below the background,
primarily hypermethylated state (Schroeder et al.,
2013). PMD presence is correlated with changes
in gene expression, and outside of placenta they
have only been observed in cancer and cultured
cell lines (excluding ESCs and iPSCs). (Hansen
et al., 2011; Lister et al., 2009).
A recent study found that despite widespread
morphological changes, the placenta’s globally
lowered methylation state is a common feature
across mammalian species (Schroeder et al.,
2015). Reduced levels of methylation may
allow for species-specific endogenous retroviral
activity in the placenta, and could represent
regulatory variation that is typically silenced
in other tissues (Chuong et al., 2013). Prior
work also observed similarity between trophoblast
methylomes and oocytes, suggesting minimal
de novo methylation in extraembryonic-derived
tissues following fertilization (Schroeder et al.,
2015). Knocking out de novo methyltransferases
Dnmt3a/3b in trophoblasts resulted in few defects
compared to wild type at embryonic day 9.5,
further supporting a reduction or lack of de novo
methylation in placenta to that timepoint (Branco
et al., 2016).
Little is known about how the placental
epigenome varies within an individual species.
A full understanding of this within-species
heterogeneity must precede the identification of
meaningful between-species differences. In this
study, we explored the placental methylome from
6 strains of 3 closely related mouse species
and report a globally deregulated epigenome
relative to other differentiated tissues. Species-
specific methylation patterns primarily existed
inside retrotransposon subfamilies, particularly in
RLTR10 and RLTR20 subfamilies. Regulatory
regions such as CpG islands and promoter
regions displayed conservation across species.
Promoter methylation levels showed a unique
distribution wherein highly methylated promoters
displayed intermediate methylation levels, rather
than near-complete methylation as observed in
other tissues. We used differential expression
between placenta and other tissues to show that
this intermediate methylation remains associated
with gene repression.
Additionally, we produced the first purified
methylomes of the functionally distinct placental
junctional and labyrinthine zones at two
developmental timepoints. We identified a subtle
but consistent hypomethylation of the junctional
zone globally, as well as many concentrated
differences at gene promoters. Promoter
differences were enriched on the X chromosome,
and most differentially methylated promoters were
hypermethylated in the junctional zone relative to
the labyrinthine. Differential methylation between
developmental timepoints uncovered evidence
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for progressive PMD formation in the placenta
as well as widespread de novo methylation,
suggesting a role for the epigenome in mediating
differentiation of the layers towards term. In spite
of earlier studies suggesting the methylation in
the placenta is static, our studies demonstrate
a dynamic methylation program that varies by
species, genetic strain, layer, and developmental
timepoint.
Results
Our study relied upon two datasets, which we will
refer to as the “interspecific” and “intraspecific”
datasets, respectively. The interspecific dataset
included 12 WGBS methylomes from three
species, including four samples from each of Mus
musculus musculus, M. m. domesticus, and M.
spretus. We reduced the potential confounds of
inbreeding and litter effects by inter-crossing two
strains per species. We sequenced to an average
depth of 6.2x per covered CpG per sample, and
surveyed an average of 77% of CpGs genome-wide
per placenta.
The intraspecific dataset concentrated on a
single genetic strain, C57BL/6J, the genome
reference. We produced 24 WGBS methylomes
from the two main placental layers (labyrinthine
zone [LZ] and junctional zone [JZ]), from two
developmental timepoints (embryonic days 15
[E15] and 18 [E18]), and from male and female
siblings collected from three different litters.
In this intraspecies dataset, each sample was
sequenced to an average depth of 1.45x per
covered CpG, and surveyed on average 50% of
CpGs genome-wide. Replicates for each factor
allowed us to combine these methylomes for high
coverage where necessary and increase statistical
power to detect differences across factors. Due to
poor quality one sample was thrown out.
The full experimental design and quality control
statistics for all methylomes produced for this
study can be found in Supplemental Figure 1 and
Supplemental Tables 1 and 2, and descriptions
of the mouse strains used can be found in the
Methods.
Placenta DNA methylation is globally
heterogeneous but highly conserved at
regulatory regions
We observed global hypomethylation of the mouse
placenta relative to other tissues: genome-wide
methylation levels across interspecific samples
ranged from 43.3% to 53.8%, and varied by species
(ANOVA, p<0.015). Comparison of placental
methylation levels in whole placental samples at
single CpG resolution also revealed significantly
higher within-tissue heterogeneity when compared
with other fully differentiated tissues. To illustrate
this, we computed the Pearson correlation and
Euclidean distance between all pairs of whole
placenta samples from the same species. We
plotted these as a boxplot, together with
boxplots of pairwise correlation and distance for
three other tissues: brain (Lister et al., 2013),
instestine (Hon et al., 2013; Kaaij et al., 2013;
Sheaffer et al., 2014) and blood (Kieffer-Kwon
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et al., 2013) (Figure 1A). Despite this within-
tissue variability, genome-wide methylation levels
clustered reasonably well by strain and species
in the placenta (Figure 1B), although they
did not precisely capture the true species-level
evolutionary relationship (Sarver et al., in press;
Tucker, 2006). Intra-species samples clustered well
by layer, however both comparisons of single-CpG
heterogeneity and pairwise binned correlations
suffered from substantially lower sequencing depth
(Supplemental Figure 2A,B). In the intraspecific
dataset, the junctional zone was less methylated
than the labyrinthine zone (p<0.017) (Figure 1C),
but there was no significant difference in global
levels of CpG methylation by developmental
timepoint or sex.
DNA methylation is an important component
of transcriptional regulation, with methylation
of retrotransposons and gene promoters strongly
correlated with their repression (Boyes and Bird,
1991). Figure 1D presents methylation levels in
gene promoters in the placenta of each mouse
species and high quality WGBS embryonic stem
cell (ESC) methylomes from four separate projects
curated in MethBase (Harten et al., 2015; Li
et al., 2015; Lu et al., 2014; Song et al.,
2013; Yearim et al., 2015). In the placenta,
promoter methylation remained bimodal, but
with the high mode typically associated with
transcriptional repression shifted from the near-
complete methylation seen in other tissues to
intermediate levels.
To explore how this reduced promoter
methylation level might relate to transcriptional
regulation, we identified differentially expressed
(DE) genes between 5 E14.5 C57Bl6/J x
FVB/n mouse placenta RNA-seq experiments
(Mould et al., 2013) and ESC RNA-seq data
derived from two of the studies above with
matched methylation and expression data (Lu
et al., 2014; Yearim et al., 2015). We identified
differentially expressed genes (see Methods)
and plotted them by their normalized counts
and log fold change between ESC and placenta
(Supplemental Figure 3A). We filtered for
DE genes with a log-fold change of greater
than 5 and counts per million of less than 5,
leaving us 797 and 733 DE genes expressed
higher in placenta and ESC, respectively, and
plotted the promoter methylation distributions
for these genes (Figure 1E). For genes that
were higher expressed in placenta, we observed
nearly complete methylation of the promoter
in ESCs and hypomethylation of the promoter
in placenta. In genes higher expressed in ESCs
however, the promoter methylation levels of
placenta reached only intermediate levels.
This pattern was conserved when considering
the promoter methylation distributions of
differentially expressed genes between placenta
and other tissues, including brain (Lister et al.,
2013), intestine (Sheaffer et al., 2014), and blood
(Kieffer-Kwon et al., 2013) (Supplemental Figures
3 and 4, all DE genes included in Supplemental
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Table 3). These observations indicate that
epigenomic repression of transcription in the
placenta does not require methylation levels as
high as seen in other tissues.
Another unique feature of the placental
methylome is the hypomethylation of
retrotransposons. Almost all retrotransposons
are methylated in most other tissues, but show a
relaxed methylation state in the placenta (Figure
1F). Of the 2,191,618 annotated retrotransposons
overlapping at least one CpG, we sequenced to
a depth of at least 5 observations per copy in
96.2%, 95.0%, and 81.9% of all retrotransposons
in M. m. domesticus, M. m. musculus, and M.
spretus respectively (see Methods). Comparisons
of these interspecies samples revealed uniformly
high correlation and low Euclidean distance
for promoters and CpG islands, indicating
conservation of epigenomic state at these
regulatory regions. In contrast, we observed
strong species-specific patterns in all classes of
retrotransposons (Figures 1G,H). These patterns
are consistent with an arms race hypothesis
(Crespi and Nosil, 2013), where methylation
divergence is driven by conflict with genomic
parasites.
Quantifying species- and layer-specific
methylation changes in the placenta
To identify the biologically meaningful and
statistically significant epigenetic differences
driven by species, layer, and developmental
timepoints, we used RADMeth to find
differentially methylated (DM) CpGs, combine
the p-values of neighboring (within 100bp) CpGs,
and perform false discovery rate correction
according to Benjamini and Hochberg (1995).
To compare species, we identified DM CpGs
for each species relative to the other two species
combined. This allows us to identify features
specific to each species.
To compare layers and developmental
timepoints, we accounted for the full experimental
design to avoid confounding by other factors.
Importantly, we removed one female sample
from the junctional zone (M1043-F5-F15-JZ)
from the same developmental timepoint as the
missing LZ sample to ensure equal numbers of
male and female samples while calling differential
methylation. Principle component analysis (Wold
et al., 1987) using our identified DM CpGs as
the feature set for each factor showed a clear
segregation by factor status (Supplemental Figure
5). Most of the significantly DM CpGs between
layers are hypomethylated in the junctional zone
relative to the labyrinthine zone (Figure 2A).
We also detected a sizeable number of CpG
sites whose methylation level increased between
E15 and E18 (Figure 2B), suggesting that while
previous studies on Dnmt3a/b knockout mice
revealed normal trophoblast formation during
early development, de novo methylation likely
plays a role in the late stage development and
differentiation of the placental layers.
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FIG. 1. DNA methylation is variable in the placenta, except at regulatory regions. (A) Pearson correlation and Euclidean
distance between pairs of whole placenta samples, compared with pairwise correlation and distance between samples of other
tissues at single CpG resolution. (B) Hierarchical clustering of pairwise binned correlation for whole placental samples in
1kb bins. Three-letter codes indicate genetic strain, number indicates individual. (C) Global methylation between layers,
timepoints, and sex. (D) Promoter methylation density plot comparing inter-species placenta and ESCs. (E) Promoter
methylation distributions in placenta and ESC for genes upregulated in placenta (left) and ESC (right). (F) Retrotransposon
methylation density plot. (G, H) Within- and between-species pairwise correlation and distance by genomic feature.
To identify the sources of species-, layer-, and
age-specific variation, we investigated DM CpG
occupancy inside various genomic regions (Figure
2C). We observed an order of magnitude more
differences by species than by layer or age, and
DM CpGs seem to be uniformly distributed
throughout the genome. To identify the DM CpGs
that are most likely to drive meaningful differences
in transcriptional regulation, we focused on those
located in gene promoters. For each promoter, we
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counted the number of significantly DM CpGs
with at least 30% methylation difference between
levels for each factor. Between layers, this yielded
5 genes with at least 10 DM promoter CpGs, with
the top two (Srrt and Zmym3) having 45 and 25
DM CpGs respectively. Three of these genes were
on the X-chromosome, and analysis of male and
female samples separately show conservation of
magnitude and directionality of this differential
methylation between sexes (Supplemental figure
6A-C). Subject to the same analysis, differences
between ages yielded only 2 genes with at least
10 DM CpGs (Table 1). Of note, the next
highest difference between ages (8 DM CpGs) was
Tjp1, a human ortholog of which was previously
associated with trophoblast cell differentiation
and whose promoter was methylated in E18
samples (Pidoux et al., 2010). No gene set was
enriched for placenta-related gene ontology terms.
Interestingly, differentially methylated gene
promoters between layers were enriched on the
X-chromosome and primarily hypermethylated
in the junctional zone, despite most DM CpGs
showing junctional hypomethylation. An example
of junctional zone promoter hypermethylation is
shown in Figure 2D.
An analysis of the X-chromosome revealed
global hypomethylation relative to autosomes (p<
3.56e−05, Supplemental Figure 7A) in females
but similar methylation levels in males. We
also observed elevated methylation levels in
CpG islands of both male and female X
chromosomes relative to autosomes, but with
greater levels in female placentas (p<2.21e−10,
Supplemental Figure 7B), suggesting CpG islands
have elevated methylation levels on the inactive
X. The male CpG island methylation increase is
slightly enriched in the junctional layer (p<0.03,
Supplemental Figure 7C).
To better understand the strong species-specific
retrotransposon signals we observed, we utilized
the RepeatMasker annotation of retrotransposons
in the LINE, SINE, and LTR classes, which
was downloaded via the UCSC Table Browser
tool (Karolchik et al., 2004). We computed the
enrichment of species-specific DM CpGs in each
retrotransposon subfamily given each subfamily’s
total CpG density. The distribution of observed
over expected (O/E) ratios of DM CpG occupancy
inside retrotransposon subfamilies is notably
shifted to the right, indicating that almost all
retrotransposon subfamilies are more differentially
methylated between species than expected by
chance (Figure 3E). By filtering for subfamilies
with at least 50 DM CpGs and O/E ratio of at
least 2x, we saw almost exclusive enrichment in
RLTR10 and RLTR20 subfamilies (Supplemental
Table 4), notably in the same broad group of ERVs
(ERV2) as the retrotransposons bearing species-
specific enhancers identified previously (Chuong
et al., 2013).
8
“Decato-Placenta-2017” — 2017/3/16 — 10:52 — page 9 — #9i
i
i
i
i
i
i
i
Mouse placenta · doi:10.1093/molbev/mst012 MBE
A
5 kb
Prrg3
D
Labyrinthine
Junctional
chrXqA7.3 mm10
B
Layer
Age
Spretus
Musculus
Domesticus
Promoter
Exon
SINE
LTR
LINE
Intergenic
0.0 0.2 0.4 0.6 0.8 1.0
Prop. DM CpGs
C
Layer DM CpGs Age DM CpGs
E
Subfamily log(observed/expected)
Species DM CpG enrichment in repeats
−2.5 −2.0 −1.5 −1.0 −0.5 0.0 0.5 1.0
0
0.
02
0.
06
0.
10
Pr
op
or
tio
n
n =   229578
n =     41450
n = 6274232
n = 4562165
n = 2946231
0
1
0
1
E18−E15 (%mCpG)
Pr
op
or
tio
n
−0.4 −0.2 0.0 0.2 0.4
0
0.
05
0.
1
JZ−LZ (%mCpG)
Pr
op
or
tio
n
−0.4 −0.2 0.0 0.2 0.4
0
0.
15
0.
07
5
FIG. 2. Methylomes differ between layers, developmental timepoints, and species. (A, B) Directional DM CpG methylation
distributions between layer and age. (C) DM CpG quantity and location by genomic region, with N equal to the total number
of DM CpGs for each factor. (D) Example promoter that is differentially methylated between layers. (E) Distribution
of enrichment of M. musculus-specific DM CpGs in retrotransposon subfamilies, showing enrichment (log O/E >0) of
differential methylation in almost every subfamily.
Rank Layer # DM CpGs Age # DM CpGs
1 Srrt 45 Cdc42 16
2 Zmym3* 25 Picalm 12
3 Stag2* 25 Tjp1 8
4 Prrg3* 11
5 1810009A15Rik 10
Table 1. Top differentially methylated promoters between placental layers and developmental timepoints. Between layers,
there is an enrichment for X-chromosome genes (asterisk).
Progressive PMD formation in the mouse
placenta
PMDs are megabase-scale stretches of the genome
with consistently low methylation relative to
the background of genome-wide equilibrium
methylation level. They were first observed in
human immortalized cell lines (Lister et al.,
2009) and later found to be present in cancer
(Berman et al., 2012; Hansen et al., 2011) and
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then observed in human placenta methylomes
(Schroeder et al., 2013). In contrast to a prior
study that reported the absence of PMDs in
mouse placenta (Schroeder et al., 2015), we
identified a highly reproducible segmentation of
the methylome in all three mouse species into
background and PMD regions using the HMM
approach described in Song et al. (2013) (Figure
3A). This method segments the methylome based
on consecutive observations of weighted average
methylation levels inside 1kb bins, reducing the
effect of local hypermethylation introduced by
regulatory regions such as gene promoters or
enhancers. We compared the previously reported
mouse placenta methylome to our own data and
found PMDs covering 26.5% of the genome and
reaching similar in-PMD methylation levels to our
own using the same identification technique, with
a bin size of 20kb to compensate for substantially
lower coverage than our own whole placental
samples (Supplemental Figure 8A).
Placental PMDs are located in gene poor
regions and exist in both layers of the placenta
(Figure 3A). Taking the union of PMDs across
all inter-specific samples, we observed an overlap
with 8,828 gene promoters compared with an
expected 12,025, given the size of the genome
and assuming a hypergeometric distribution
of the overlaps. While PMD locations stayed
generally constant, the overall fraction of the
genome inside PMDs varied substantially, from
nearly absent in the MPB strain to extremely
prevalent in the DOT strain (Figure 3B). For this
interspecific data, the collection method for the
whole placenta samples allowed the age of the
embryo at dissection to vary up to 5 days (see
Methods), and we observed an order-of-magnitude
decrease in embryonic weight in the MPB strain
that coincided with an earlier developmental
stage and absent PMDs (Supplemental Table 1).
Therefore we hypothesized that PMDs gradually
appear over developmental time in the placenta.
In the intraspecific data, analysis of PMD
size between developmental timepoints in late
gestation revealed an increase in the size of PMDs
between E15 and E18 (p<0.032) (Figure 3C).
While PMDs widened over time, the methylation
level inside PMDs did not show significant
differences between timepoints (p<0.47). The
methylation levels outside of PMDs increased
slightly but not significantly, consistent with
the observed global methylation levels of the
two timepoints. Corroborating the observations
reviewed in Novakovic and Saffery (2013), the
Dnmt1 promoter is hypomethylated in mouse
placenta at all timepoints, in all layers, and in
all species, suggesting that PMD formation in the
mouse placenta is likely not driven by differential
expression of Dnmt1.
The globally lower methylation level in M.
spretus compared to the other two species led
to lower average methylation inside PMDs (p<
0.0006) (Figure 3D) but similar PMD depth.
Interestingly, despite the lack of PMDs in MPB
10
“Decato-Placenta-2017” — 2017/3/16 — 10:52 — page 11 — #11i
i
i
i
i
i
i
i
Mouse placenta · doi:10.1093/molbev/mst012 MBE
leading to large overall methylation differences
between those and the other M. musculus samples
(Figure 3E), CpG island methylation remained
extremely close regardless of PMD presence. This
suggests that CpG islands remain under direct
regulation even inside PMDs (Figure 3F). Average
methylation levels for CpG islands inside PMDs
were slightly elevated in our mouse placenta
samples, corroborating the finding in (Schroeder
et al., 2013). However, few CpG islands inside
placental PMDs displayed methylation above 80%
(Supplemental Figure 8B), while methylation of
CpG islands inside cancer PMDs regularly exceeds
80% (Hansen et al., 2011; Toyota et al., 1999).
Discussion
The placenta is a rapidly evolving organ that
plays a temporary but essential role in mammalian
development. In this study, we explored the
role of the placental epigenome on its function
and evolution. We characterized the placental
epigenome as globally deregulated, possessing
within-tissue methylation variance substantially
higher than in other differentiated tissues. This
noisy and globally hypomethylated state, relative
to other tissues, remains a fundamentally distinct
and poorly understood feature of placental
cells. Recent studies have shown that this low
methylation likely originated very early and
persists through the trophoblast lineage (Branco
et al., 2016). In addition, the globally low
rate of methylation appears to be a common
feature across distant species of mammal (Branco
et al., 2016; Schroeder et al., 2015). We showed
that global variation in placental methylation
is conserved in differentiated placental layers
and across later timepoints. The source of this
variability could be rooted in the placenta’s
transient nature, allowing its epigenome to erode
during development without much harm to the
overall success of the embryo. Another possibility
is that the placenta’s adaptive response to its
environment (Fowden and Moore, 2012; Sferruzzi-
Perri and Camm, 2016) manifests in global
methylation changes in subpopulations of cells
not yet detectable without applying single-cell
methods.
Despite globally heterogeneous methylation
patterns, we observed similar levels of methylation
across species at regulatory regions, including
gene promoters and CpG islands both inside
and outside of promoters (as annotated in
the UCSC table browser, see Methods). While
methylation in placental promoters showed
within-tissue consistency, the actual distribution
was placenta-specific, showing a shift in the “high”
methylation range that remained correlated with
repressive effects on gene expression. This opens
up an interesting question: if the background
methylation level in differentiated somatic cells is
higher than needed for its role in gene expression,
why does it remain at consistently high levels with
such small variation between somatic cell types?
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FIG. 3. Partially methylated domains exist in mouse placenta and are spatially conserved across species. (A) Methylation
levels (yellow barplots) and identified PMD locations (grey boxes) in a selected genomic interval; genes shown in blue. (B)
Genomic fraction covered by PMDs in whole placenta samples. (C) Genomic fraction covered by PMDs at E15 and E18
in intra-specific samples. (D) Distributions of CpG methylation levels inside and outside PMDs in M. spretus and non-M.
spretus samples. (E) Pairwise distances between genome-wide methylation profiles (average level in 1kb bins). (F) Pairwise
distance by species in CpG islands.
We produced the first methylomes of the
junctional and labyrinthine zones and observed
substantial de novo methylation between E15 and
E18. Our results suggest that while Dnmt3a/3b
may not be necessary in the early development of
the trophoblast (Branco et al., 2016), it could play
a role in later maturation of the placental layers.
Using male and female placental methylomes, we
indirectly explored methylation on the inactivated
paternal X chromosome in females. We identified
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globally lower methylation levels in females,
but elevated CpG island methylation on the X
chromosome, which contributes to X inactivation
(Csankovszki et al., 2001).
The impact of the globally lowered methylation
state on retrotransposon activity in the placenta
also remains poorly understood. Our analysis
revealed that retrotransposon families were
more likely to show species-specific methylation
than expected, with differentially methylated
CpGs especially enriched in members of the
RLTR10 and RLTR20 subfamilies. This pattern
stands in stark contrast to non-placental tissues,
where retrotransposons are usually methylated
(Bestor, 2000). This elevated tolerance to retro-
element hypomethylation and expression may be
required for placenta-specific phenomena, such
as previously identified exaptation events of
specific retrotransposons by the placenta to evade
the maternal immune system (Feschotte and
Gilbert, 2012; Mi et al., 2000) or co-option of
certain retrotransposon subfamilies as placenta-
specific enhancer elements (Chuong et al., 2013).
In contrast to the study by Chuong et al.
(2013), which identified placenta-specific enhancer
elements at mouse-specific retrotransposons not
present in the rat, we identified differential
methylation in retrotransposons that are present
in all species studied. This could represent more
recent adaptations of the placental regulatory
program, although further study is needed.
Though selection to maintain genome integrity
in extra-embryonic tissues will certainly be
lower than in the embryo or its germline, too
much retro-element expression still represents
a potential danger to genome integrity. Retro-
element hypomethylation may be possible due
to the redundant nature of mechanisms for
retrotransposon silencing (Aravin et al., 2007;
Reichmann et al., 2013), allowing their sequences
to act as an enhancers for nearby genes while
limiting their transcriptional activity. In turn,
differentially methylated subfamilies may help
fuel the rapid diversification of placenta-specific
regulatory networks. Although the mechanisms
of retrotransposon-derived enhancers have been
studied previously (McDonald et al., 1997; Ruda
et al., 2004), further study is needed to explore
the direct impact of differential retrotransposon
methylation state between species on the
transcription of nearby orthologous genes, and
to understand what, if any, role retrotransposon-
mediated transcription may play in the human
placenta.
To function properly, the placenta must invade
and integrate with maternal tissues, a process
that shares some similarities to the invasive
behaviors of some cancers (Novakovic and Saffery,
2013). Partially methylated domains exist in
the mouse placenta, are absent in our smallest,
developmentally young embryos, and widen
between E15 and E18, suggesting that they arise
as a function of developmental time. These PMDs
13
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share conserved locations across species, layer,
and are found in the same gene-poor regions as
in cancers. PMDs correlate with late replicating
domains in human (Berman et al., 2012), and
therefore may arise in both cancer and placental
cells as a consequence of rapid cell division
outpacing the maintenance of methylation in
these regions. CpG island hypermethylation is a
hallmark of cancer methylomes and is enriched
within cancer PMDs. Mouse placenta PMDs show
no CpG island hypermethylation of the type
reported in the PMDs of cancer methylomes
(Berman et al., 2012). Further studies are required
to determine if PMDs have any significance in
placental function. However, this shared feature
of placental and cancer methylomes is striking
and any model to explain PMDs will be more
appealing if its explanatory power extends to both
cancer and placenta epigenomes.
Materials and Methods
Inter-species whole placenta tissue collection
All animal husbandry, experimental procedures,
and personnel were approved by the University of
Southern California’s Institutional Animal Care
and Use Committee, protocol #11394. Mice
were housed under a 14:10 hour light cycle
with food and water ad libidum. To investigate
species differences in placental methylation,
crosses between wild derived inbred strains were
established, developed and distributed by Franc¸ois
Bonhomme and colleagues (U. Montpellier).
For M. domesticus, we made reciprocal crosses
between strains BIK (originally isolated from
Kefar Galim, Israel) and DOT (Tahiti); for M.
musculus, MPB (Bialowieza, Poland) and MBS
(Sokolovo, Bulgaria); and for M. spretus, STF
(Fondouk Djedid, Tunisia) and SFM (Montpellier,
France). For all crosses, a single stud and dam
were housed together for four and a half days, and
then split. 10 days later, females were euthanized,
uteri were collected and the number of viable
conceptuses counted, leading to gestational ages
between E11 and E16. The embryos and placenta
were dissected and weighed. Two placentae were
sampled from a single litter in each cross direction
and snap frozen in liquid nitrogen. Placenta
are named according to their maternal strain.
We attempted to sample only female placenta,
through two replicated attempts to PCR-amplify
two Y- and one X-linked region (Kunieda et al.,
1992), but for logistical reasons we had to include
two male placentae.
Intra-species junctional and labyrinthine zone
tissue collection
All experiments were carried out under the UK
Home Office Animals (Scientific Procedures)
Act 1986. C57Bl/6 females were housed under
dark:light 12:12 conditions with free access to
water and the standard diet used in the University
of Cambridge Animal Facility. At 8-10 weeks,
females were mated with C57Bl/6 males and the
day a copulatory plug was found was denoted
as embryonic day 1 of pregnancy (term=20.5
days). On embryonic days 15 or 18 of pregnancy
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(days correspond to the periods of rapid placental
and fetal growth respectively), mouse dams
were schedule 1 killed by cervical dislocation.
Uteri were collected and the number of viable
conceptuses counted. Embryos and placentas were
dissected and weighed. Each placenta from the
litter was rapidly separated into the functionally
distinct zones, the labyrinthine transport and
junctional endocrine zones (Sferruzzi-Perri et al.,
2009), in ice cold sterile PBS before rapid
snap freezing in liquid nitrogen. Fetal tails
were kept for sexing using standard genotyping
methods including using primers to detect the
SRY gene (5’-CCCAGCATGCAAAATACAGA
-3’ and 5’-TCAACAGGCTGCCAATAAAA-
3’), an internal control gene (5’-
AGTGGCTAACGCTGAGTGGT-3’ and
5’-GTGCCTGTCGGAGGAGAAC-3’) and
with agarose gel electrophoresis. From each litter,
the male and female placenta with its weight
closest to the litter mean was used for further
analysis.
DNA Extraction and Methylation Assay
Using a Qiagen DNA extraction kit, DNA was
extracted and purified for all inter- and intra-
species samples. DNA was fragmented to 100-
300bp fragments by sonication and end repaired
before ligation of methylated sequencing adapters.
Bisulfite treatment was performed using the Zymo
EZ DNA Methylation Gold kit. Following bisulfite
treatment, DNA fragments were de-salted and
size selected to produce a 200-300bp short-insert
library, subjected to PCR, and size selected again
before 100bp paired-end reads were sequenced
using an Illumina Hiseq4000.
Data Analysis
Reads were mapped to the mm10 reference
genome using WALT (Chen et al., 2016).
Calculation of methylation levels, bisulfite
conversion rate, and identification of PMDs was
performed as described in (Song et al., 2013),
and all values are available in Supplemental
Tables 1 and 2. Weighted methylation levels as
defined by Schultz et al. (2012) were used to
calculate average methylation levels in genomic
regions. All browser plots were created using
the UCSC genome browser tool (Kent et al.,
2002). Promoters were defined as +/-1kb from
the mm10 RefSeq TSS based on the observation
that hypomethylation frequently occurs there on
the kilobase scale (Molaro et al., 2011). CpG
islands were identified as described in Gardiner-
Garden and Frommer (1987). Retrotransposon
copies were annotated by RepeatMasker (Smit
et al., 1996) and analysis was performed only
on the LINE, SINE, and LTR classes (removing
all non-retrotransposons from the annotation).
Pearson correlation and Euclidean distance at
single CpG resolution in whole placenta samples
were calculated from the 2,801,446 CpG sites
with 5x or greater sequencing depth across
all samples. Pairwise comparisons between
whole placental samples included only within-
species comparisons. Intraspecies single CpG site
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correlations and distances were computed from
8,180 CpG sites with 3x or greater sequencing
depth across all samples. Boxplots for brain,
intestine, and blood were produced with a
random set of CpG sites downsampled to the
number covered in placental samples. Pearson
correlation, Euclidean distance, and distributions
were produced using only promoters, CpG
islands, and retrotransposons with at least 5 CpG
observations to reduce the discretizing effect of
low-coverage observations.
ANOVA between global methylation levels with
species as the factor was performed in R as
a one-way analysis of variance. Differentially
methylated CpGs between species were called
using (Dolzhenko and Smith, 2014) with species-
specific methylation signatures identified using
the other two species as background samples.
Multiple testing correction of combined DM CpG
p-values was done as described in (Benjamini and
Hochberg, 1995) using an alpha level of 0.05.
Observed over expected (O/E) ratios used for
enrichment and depletion analysis of subfamilies
were calculated as follows:
O
E
=
DM CpGs in subfamily
DM CpGs total
/
CpGs in subfamily
CpGs genome-wide
(1)
Public RNA-seq reads were mapped using
STAR (Dobin et al., 2013). BAM files were
converted to read counts using HT-seq (Anders
et al., 2014) and differentially expressed genes
were identified using edgeR (Robinson et al.,
2010). We placed an upper bound on the counts
per million (CPM) of differentially expressed
genes analyzed to focus on those genes that were
nearly silenced in one cell type relative to the
other.
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